Ipamorelin 10mg Peptides
Precision starts with uncompromising materials.
Well Elevation Ipamorelin is a lyophilized research peptide supplied as a single-vial format with a total content of 10mg. Presented as a clean, stable powder, this vial is intended for controlled laboratory work where consistency and traceability matter. As part of our GH peptide collection, this lot reflects our emphasis on purity, identity, and careful handling from reception to release.
- Each vial contains 10mg of Ipamorelin, a selective growth hormone secretagogue studied for targeted GH pathway activation with minimal off-target activity in preclinical models, supporting rigorous assay design and repeatable data.
The lyophilized presentation is designed for stability and reliable preparation in qualified research settings. Users can expect a uniform appearance and a material that is engineered to support precise measurement, method development, and reproducibility across protocols. This format suits laboratories prioritizing controlled conditions and clean sample preparation for in vitro or ex vivo applications.
Every Well Elevation peptide is produced with disciplined attention to detail. Identity and purity are verified by analytical methods such as HPLC and mass spectrometry, with strict lot control and documented chain-of-custody throughout handling. Batches are managed under rigorous quality systems to reduce variability and to maintain confidence in the material you receive. Packaging is professional and secure, with tamper-evident features to protect integrity from our facility to your lab bench.
Our USA-based operations center the fundamentals: exacting specifications, clear documentation, and a conservative approach to quality so that researchers can focus on data, not uncertainty. For laboratories that prioritize dependable materials, this 10mg Ipamorelin vial offers a straightforward, disciplined option aligned with modern peptide research standards.
Quality and Compliance
- USA-based sourcing and handling with rigorous standards
- Analytical verification (HPLC/LC-MS) for identity and purity
- Lot-level traceability and controlled storage practices
- Professional, tamper-evident packaging
Research Use Only. Not for human consumption. Not a drug, food, cosmetic, or household chemical. Handle exclusively in qualified laboratory environments following applicable regulations and safety procedures.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Well Elevation are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
